1. Home
  2. CNX vs TVTX Comparison

CNX vs TVTX Comparison

Compare CNX & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNX Resources Corporation

CNX

CNX Resources Corporation

HOLD

Current Price

$31.99

Market Cap

4.8B

Sector

Energy

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$56.60

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNX
TVTX
Founded
1860
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.3B
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
CNX
TVTX
Price
$31.99
$56.60
Analyst Decision
Sell
Strong Buy
Analyst Count
7
13
Target Price
$35.71
$40.62
AVG Volume (30 Days)
2.0M
2.1M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
763.33
92.89
EPS
2.18
N/A
Revenue
$2,239,134,000.00
N/A
Revenue This Year
N/A
$44.76
Revenue Next Year
$11.14
$35.51
P/E Ratio
$14.97
N/A
Revenue Growth
76.76
N/A
52 Week Low
$27.72
$15.03
52 Week High
$43.62
$60.10

Technical Indicators

Market Signals
Indicator
CNX
TVTX
Relative Strength Index (RSI) 32.73 60.92
Support Level $31.69 $54.87
Resistance Level $33.98 $60.10
Average True Range (ATR) 0.81 2.13
MACD -0.02 -0.38
Stochastic Oscillator 6.04 42.04

Price Performance

Historical Comparison
CNX
TVTX

About CNX CNX Resources Corporation

CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: